SEC Comment Letter for ARGENX SE (ARGX) — Nov 14, 2017

ARGENX SE
Date: Nov. 14, 2017 · CIK: 0001697862 · Accession: 0000000000-17-040205

View on Edgar

AI Filing Summary & Sentiment

Date

November 13, 2017

Author

Not clearly detected

Form

UPLOAD

Company

ARGENX SE

Letter

November 13, 2017 Tim Van Hauwermeiren Chief Executive Officer argenx SE Willemstraat 5 4811 AH, Breda, the Netherlands argenx SE Draft Registration Statement on Form F-1 Filed November 6, 2017 File No. 377-01775Re: Dear Mr. Van Hauwermeiren: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Michael Bison

Show Raw Text

November 13, 2017
Tim Van Hauwermeiren
Chief Executive Officer
argenx SE
Willemstraat 5
4811 AH, Breda, the Netherlands
argenx SE
Draft Registration Statement on Form F-1
Filed November 6, 2017
File No. 377-01775Re:
Dear Mr. Van Hauwermeiren:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Michael Bison

SecProbe.io